Pressure BioSciences (OTCQB: PBIO), a pacesetter within the growth and sale of broadly enabling, pressure-based devices, consumables, and specialty testing companies to the worldwide biopharmaceuticals, nutraceuticals, cosmetics, agrochem and meals/beverage industries, has signed a two-year collaborative analysis and growth settlement with Dr. Adrienne Denese, MD, PhD. Creator of the award-winning SkinScience Labs, Denese is a acknowledged QVC icon, business Visionary, anti-aging pioneer and founder and president of Dr. Denese SkinScience, some of the profitable, extremely rated, and longest-lasting skincare traces within the historical past of QVC. According to the settlement, PBI and Dr. Denese SkinScience will work collectively to develop skincare tasks to pursue, growing statements of labor (“SOW”) with authorised budgets, timetables and remuneration formulation for each firms. The two firms will start by specializing in the potential for PBI’s distinctive Ultra Shear Technology(TM) (“UST”) nanoemulsification platform to boost current and develop new SkinScience skincare merchandise. “From 2019 to 2021, Dr. Denese averaged near $20 million per 12 months in complete gross sales,” mentioned Pressure BioSciences president and CEO Richard T. Schumacher within the press launch. “In 2022, with assist from new channel companion Costco, gross sales are anticipated to extend considerably. The launch of a brand new era of merchandise processed by PBI’s patented UST platform, for the first-time ever within the cosmeceuticals space, is deliberate for 2023, which we count on to end in a really fulfilling and thrilling 12 months for Dr. Denese and her loyal prospects — and for PBI. . . . Although ultimate willpower of the order of growth of those new and enhanced merchandise is but to be introduced, each Dr. Denese SkinScience and PBI perceive that these are potential game-changers in an business whose 2021 international market measurement was estimated to be over $130 billion. We take a look at this partnership as a chance for multimillion-dollar accretive income progress for each firms over the following two years, with the potential to dramatically improve the expansion trajectory and profitability of each Dr. Denese SkinScience and PBI for years to come back.”
To view the complete press launch, go to https://ibn.fm/Nq1XL
About Pressure BioSciences Inc.
Pressure BioSciences is a pacesetter within the growth and sale of progressive, broadly enabling, pressure-based options for the worldwide life sciences and different industries. PBIO’s merchandise are based mostly on the distinctive properties of each fixed (i.e., static) and alternating, or strain biking expertise (“PCT”) hydrostatic strain. PCT is a patented, enabling expertise platform that makes use of alternating cycles of hydrostatic strain between ambient and ultra-high ranges to regulate biomolecular interactions (e.g., cell lysis, biomolecule extraction) safely and reproducibly. The firm’s major focus is on the event of PCT-based merchandise for biomarker and goal discovery, drug design and growth, biotherapeutics characterization and high quality management, soil and plant biology, forensics and counter bioterror functions. Additionally, main new market alternatives have emerged for the usage of PBIO’s pressure-based applied sciences within the following areas: (1) the usage of its lately acquired, patented expertise from BaroFold Inc. to permit entry into the biopharma contract companies sector, and (2) the usage of its lately patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create steady nanoemulsions of in any other case immiscible fluids (e.g., oils and water) and to (ii) put together greater high quality, homogenized, prolonged shelf-life or room-temperature, steady, low-acid liquid meals that can’t be successfully preserved utilizing current nonthermal applied sciences. For extra data, go to the corporate web site at www.PressureBioSciences.com.
NOTE TO INVESTORS: The newest information and updates regarding PBIO can be found within the firm’s newsroom at http://ibn.fm/PBIO
About InvestorWire
InvestorWire is the wire service that provides you extra. From regional releases to international bulletins introduced in a number of languages, we provide the wire-grade dissemination merchandise you’ll want to make sure that your subsequent press launch grabs the eye of your audience and doesn’t let go. While our rivals look to nickel and dime you with hidden charges and restrictive phrase limits, InvestorWire retains issues clear.
As a part of its service, InvestorWire gives protection of noteworthy bulletins. To additional broaden visibility of achievements being made all through a large number of sectors, InvestorWire’s syndication companions have prolonged the digital protection to incorporate particular person broadcasts on monetary web sites and platforms visited by tens of millions of buyers day by day.
For extra data, please go to https://www.InvestorWire.com
Please see full phrases of use and disclaimers on the InvestorBrandNetwork web site relevant to all content material supplied by IBN, wherever printed or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)8033 Sunset Blvd Suite 1037-IWLos Angeles, CA 90046310.299.1717 Officewww.InvestorWire.com[email protected]
InvestorWire is a part of the InvestorBrandNetwork.
https://www.streetinsider.com/Investor+Brand+Network/InvestorNewsBreaks+%E2percent80percent93+Pressure+BioSciences+Inc.+(PBIO)+Partners+with+Skincare+Leader,+Icon+and+Pioneer/20503988.html
